Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy.

Literature DB >> 10833501

Vasoactive agents in intrahepatic portal hypertension and fibrogenesis: implications for therapy.

D C Rockey.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2000 PMID： 10833501 DOI： 10.1016/s0016-5085(00)70379-9

Source DB: PubMed Journal: Gastroenterology ISSN： 0016-5085 Impact factor: 22.682

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

Review 1. Angiotensin converting enzyme inhibitors and angiotensin II antagonists as therapy in chronic liver disease.

Authors: J Vlachogiannakos; A K Tang; D Patch; A K Burroughs
Journal: Gut Date: 2001-08 Impact factor: 23.059

Review 2. Role of endothelin in systemic and portal resistance in cirrhosis.

Authors: P W Angus
Journal: Gut Date: 2006-09 Impact factor: 23.059

3. Antifibrotic Effects of Carvedilol and Impact of Liver Fibrosis on Carvedilol Pharmacokinetics in a Rat model.

Authors: Ebtehal El-Demerdash; Somaia A Abdel-Sattar; Wesam M El-Bakly; Eman A Mohamed
Journal: Eur J Drug Metab Pharmacokinet Date: 2017-10 Impact factor: 2.441

4. Hemodynamic and antifibrotic effects of a selective liver nitric oxide donor V-PYRRO/NO in bile duct ligated rats.

Authors: Frédéric Moal; Nary Veal; Eric Vuillemin; Eric Barrière; Jianhua Wang; Lionel Fizanne; Frédéric Oberti; Olivier Douay; Yves Gallois; Dominique Bonnefont-Rousselot; Marie Christine Rousselet; Paul Calès
Journal: World J Gastroenterol Date: 2006-11-07 Impact factor: 5.742

Review 5. Bioconjugation of oligonucleotides for treating liver fibrosis.

Authors: Zhaoyang Ye; Houssam S Hajj Houssein; Ram I Mahato
Journal: Oligonucleotides Date: 2007

6. Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2.

Authors: Chandana B Herath; John S Lubel; Zhiyuan Jia; Elena Velkoska; David Casley; Lindsay Brown; Chris Tikellis; Louise M Burrell; Peter W Angus
Journal: Am J Physiol Gastrointest Liver Physiol Date: 2009-04-23 Impact factor: 4.052

10. Low NO bioavailability in CCl4 cirrhotic rat livers might result from low NO synthesis combined with decreased superoxide dismutase activity allowing superoxide-mediated NO breakdown: A comparison of two portal hypertensive rat models with healthy controls.

Authors: Marc Van De Casteele; Jos F Van Pelt; Frederik Nevens; Johan Fevery; Jürg Reichen
Journal: Comp Hepatol Date: 2003-01-10